The UK Heart Protection Study has demonstrated the benefits of cholesterol lowering drug Lipex, for at-risk groups such as diabetics.
With nearly 6000 diabetes patients enrolled in the study, it is the first designed to investigate the benefits of cholesterol-lowering therapy in people with Type I and Type II diabetes, with or without a prior history of heart disease or high cholesterol.
Treatment with Lipex during a five-year period could prevent heart attacks, strokes or major vascular events by about a third in patients aged 40 and older with diabetes.
Complete this month's questionnaire to qualify for extra Continuing Education credits. Click here For the answers to last month's quiz click here.
PHARMACY AWARDS
Click here for entry details for the 2003 Zuellig Pharma/Pharmacy Today Awards and to find out last year's winners. Also view and purchase photos of the 2002 Awards.
THIS ISSUE
For the leading stories in our latest issue of Pharmacy Today magazine visit our welcome page.
SUBSCRIPTIONS
To subscribe to Pharmacy Today, or to purchase The Beauty Manual or The Pharmacy Healthcare Handbook click here.
